explore -WSS

explore

author：entertainment 2025-08-12 06:43:40 - browse：17

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： ASCO Takeaways: Winners, snoozers, and the art of cancer care

hotspot

WSS

NIH confirmation hearing shows politicization of research

FDA gives detailed accounting of AI

Studies point to risks of excluding people with obesity from drug trials

Congress needs to close a vaccine

UnitedHealth CEO's Medicaid comments send insurer stocks diving

The most pressing bird flu mysteries scientists want answered

hotspot

explore

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Medical records are filled with copy

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Psychedelics group wrestles with new pharma identity

STAT Readout Newsletter: Today's biggest biotech updates

Alkermes shareholders re

Why health workers in Gaza are injured or die at high rates

Moonlake's readout produced a cash windfall. Risks remain

First Opinion Podcast: Long Covid needs a new approach

knowledge

CMS got Medicare Advantage quality rating wrong, judge rules

The most pressing bird flu mysteries scientists want answered

FDA approves Moderna’s RSV vaccine, its second licensed product

Finland to offer bird flu vaccine to select groups of people, a possible global first

STAT wants to know your pick for a great summer read or listen

First Opinion Podcast: Long Covid needs a new approach

Wikipedia

Wikipedia

hotspot

focus